Correlation between cord blood, perinatal BNP values and echocardiographic parameters in healthy Italian newborns

Early Human Development

Volumn 85, Issue 1, 2009, Pages 13-17

  Mannarino, Savina ^a   Ciardelli, Laura ^a   Garofoli, Francesca ^a   Perotti, Gianfranco ^a   Mongini, Elisa ^a   Damiano, Simona ^a   Tinelli, Carmine ^a   Cerbo, Rosa Maria ^a   Rondini, Giorgio ^a   Stronati, Mauro ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

BNP; Cord blood; Echocardiography; Newborns

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; COLOR ULTRASOUND FLOWMETRY; DIASTOLE; FEMALE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART SIZE; HUMAN; ITALY; MALE; NEWBORN; NEWBORN PERIOD; NORMAL HUMAN; PERINATAL PERIOD; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; UMBILICAL CORD BLOOD;

ELECTROCARDIOGRAPHY; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; ITALY; MALE; NATRIURETIC PEPTIDE, BRAIN; REFERENCE VALUES;

EID: 57749105520     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2008.05.008     Document Type: Article

References (26)

1. Reynolds E.W., Ellington J.G., Vranicar M., and Bada H.S. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics 114 (2004) 1297-1304
2. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Maeda Y., Fukai D., et al. Attenuation of compensation endogenus cardiac natriuretic peptide system in chronic heart failure. Circulation 96 (1997) 509-516
3. Doust J.A., Pietrzak E., Dobson A., and Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330 (2005) 625-634
4. Koch A., and Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 89 (2003) 875-878
5. Puddy V.F., Amirmansour C., Williams A.F., Singer D.R.J., et al. Plasma brain-type natriuretic peptide as predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci 103 (2006) 75-77
6. Choi B.M., Lee K.H., Eun B.L., Yoo K.H., Hong Y.S., Son C.S., et al. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 115 (2005) 255-261
7. Holmström H., Hall C., and Thaulow W. Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr 90 (2001) 184-189
8. da Graca R.L., Hassinger D.C., Flynn P.A., Sison C.P., Nesin M., and Auld P.AM.. Longitudinal changes of brain-type natriuretic peptide in preterm neonates. Pediatrics 117 (2006) 2183-2189
9. Davis G.K., Bamforth F., Sarpal A., Dicke F., Rabi Y., and Lyon M.E. B-type natriuretic peptide in pediatrics. Clin Biochem 39 (2006) 600-605
10. Nasser N., Bar-Oz B., and Nir A. Natriuretic peptides and heart disease in infants and children. J Pediatr 147 (2005) 248-253
11. Deverux R.B., and Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation 55 (1977) 613-618
12. Nir A., and Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology. J Card Fail 11 (2005) S76-S80
13. Loke J., Squire I.B., Davies J.E., and Ng L.L. Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate. Eur J Heart Fail 5 (2003) 599-606
14. Yoshibayashi M., Kamya T., Saito Y., Nakao K., Nishioka K., Temma S., et al. Plasma brain natriuretic peptides concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. Eur J Endocrinol 133 (1995) 297-299
15. Mir T.S., Laux R., Hellwage H.H., Liedke B., Heinze C., von Buelow H., et al. Plasma concentration of amino terminal pro atrial natriuretic peptide and aminoterminal pro brain-type natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics 112 (2003) 896-899
16. Kunii Y., Kamada M., Ohtsuki S., Araki T., Kataoka K., Kageyama M., et al. Plasma brain-type natriuretic peptides and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 57 (2003) 191-197
17. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
18. De Bold A.J., Bruneau B.G., and Kuroski M.L. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res 31 (1996) 7-18
19. De Bold A.J., Ma K.K., Zhang Y., De Bold M.L., Bensimon M., and Khoshbaten A. The physiological and pathophysiological modulation of the endocrine function of the heart. Can J Physiol Pharmacol 79 (2001) 705-714
20. Holmgren D., Westerlind A., Lundberg P.A., and Wahlander H. Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload. Clin Physiol Funct Imaging 25 (2005) 263-269
21. Clerico A., Recchia F.A., Passino C., and Emdin M. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol 290 (2006) 17-29
22. McGrath M.F., and de Bold A.J. Determinants of natriuretic peptide gene expression. Peptides 26 (2005) 933-943
23. Sakata Y., Yamamoto K., Masuyama T., Mano T., Nishikawa N., Kuzuya T., et al. Ventricular production of natriuretic peptides and ventricular structural remodelling in hypertensive heart failure. J Hypertens 19 (2001) 1905-1909
24. Takahashi N., Saito Y., Kuwahara K., Harada M., Kishimoto I., Ogawa Y., et al. Angiotensin II-induced ventricular hypertrophy and extracellular signal-regulated kinase activation are suppressed in mice overexpressing brain natriuretic peptide in circulation. Hypertens Res 26 (2003) 847-853
25. Hirataa Y., Matsumoto A., Aoyagia T., Yamaoki K., Komuro I., Suzuki T., et al. Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload. Card Res 51 (2001) 585-591
26. Maron B.J., Tholakanahalli V.N., Zenovich A.G., Casey S.A., Duprez D., Aeppli D.M., et al. Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation 109 (2004) 984-989